News | July 22, 2014

Seven presentations at the 2014 American Association of Physicists in Medicine (AAPM) meeting focus on early adopters' work with Varian's Edge radiosurgery


July 22, 2014 — Medical researchers have confirmed the Edge radiosurgery system from Varian Medical Systems can deliver dose to a targeted tumor with sub-millimeter isocenter accuracy.  The researchers, from the Champalimaud Centre for the Unknown in Lisbon, Portugal, and other teams from the Henry Ford Health System in Detroit, Michigan, made seven scientific presentations about the Edge system during the 2014 American Association of Physicists in Medicine (AAPM) meeting from July 20-24. 

The Champalimaud team worked with scientists from Varian to conduct "end-to-end" testing of the Edge system, to demonstrate its diverse subsystems can work together to yield sub-millimeter accuracy when delivering dose.

Investigators from the Henry Ford Health System did early work with the Edge radiosurgery system covering a wide spectrum of clinical issues, from the accuracy of patient setup for image-guided intracranial (brain) radiosurgery to methods for accurately commissioning a new Edge system. One of the Henry Ford teams presented preliminary data on the accuracy of dose calculations for treating small, elongated tumors with radiosurgery. 

The Edge radiosurgery suite combines Varian's world-class technologies in an end-to-end solution for planning and delivering radiosurgery treatments. It integrates Varian's most advanced medical linear accelerator — a machine that produces the high energy X-ray beams used to treat disease — with tools for real-time imaging, tumor tracking, motion management and patient positioning. The Edge enables fast, accurate delivery of stereotactic radiosurgery for treating lesions, tumors and conditions anywhere in the body where radiotherapy is indicated, including tumors of the lung, prostate, spine and brain.

For more information: www.varian.com


Related Content

News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
Subscribe Now